Article
MYC as a Target for Cancer Treatment: from Undruggable to Druggable?
15 Aug 2025
Abstract excerpt
MYC is one of the most frequently altered genes in cancer with an estimated 70% prevalence of deregulation. Deregulated MYC is believed to promote cancer formation/progression via multiple mechanisms including tumour cell intrinsic mechanisms, altering the tumour microenvironment and promoting host immune suppression. Owing to the high prevalence of alterations and its causative role in tumorigenesis, MYC is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
